Literature DB >> 22105442

Absorption enhancers: applications and advances.

Bruce J Aungst1.   

Abstract

Absorption enhancers are functional excipients included in formulations to improve the absorption of a pharmacologically active drug. The term absorption enhancer usually refers to an agent whose function is to increase absorption by enhancing membrane permeation, rather than increasing solubility, so such agents are sometimes more specifically termed permeation enhancers. Absorption enhancers have been investigated for at least two decades, particularly in efforts to develop non-injection formulations for peptides, proteins, and other pharmacologically active compounds that have poor membrane permeability. While at least one product utilizing an absorption enhancer for transdermal use has reached the market, quite a few more appear to be at the threshold of becoming products, and these include oral and transmucosal applications. This paper will review some of the most advanced absorption enhancers currently in development and the formulation technologies employed that have led to their success. In addition, a more basic review of the barriers to absorption and the mechanisms by which those barriers can be surmounted is presented. Factors influencing the success of absorption-enhancing formulations are discussed. If ultimately successful, the products now in development should offer non-injection alternatives for several peptide or protein drugs currently only administered by injection. The introduction of new absorption enhancers as accepted pharmaceutical excipients, and the development of formulation technologies that afford the greatest benefit/risk ratio for their use, may create opportunities to apply these enabling technologies more broadly to existing drugs with non-optimal delivery properties.

Mesh:

Substances:

Year:  2011        PMID: 22105442      PMCID: PMC3291189          DOI: 10.1208/s12248-011-9307-4

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  32 in total

Review 1.  Skin absorption enhancers.

Authors:  A C Williams; B W Barry
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1992       Impact factor: 4.889

2.  The effect of absorption enhancers on the oral absorption of the GP IIB/IIIA receptor antagonist, DMP 728, in rats and dogs.

Authors:  D L Burcham; B A Aungst; M Hussain; M A Gorko; C Y Quon; S M Huang
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

3.  Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines.

Authors:  B J Aungst; J A Blake; M A Hussain
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

Review 4.  Oral insulin: the rationale for this approach and current developments.

Authors:  Ehud Arbit; Miriam Kidron
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

5.  Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats.

Authors:  Hongjian Zhang; Ming Yao; Richard A Morrison; Saeho Chong
Journal:  Arch Pharm Res       Date:  2003-09       Impact factor: 4.946

6.  Thiolated polycarbophil as an adjuvant for permeation enhancement in nasal delivery of antisense oligonucleotides.

Authors:  A Vetter; R Martien; A Bernkop-Schnürch
Journal:  J Pharm Sci       Date:  2010-03       Impact factor: 3.534

7.  Subchronic oral toxicity of salcaprozate sodium (SNAC) in Sprague-Dawley and Wistar rats.

Authors:  M Gary I Riley; M Cristina Castelli; Ellen Angela Paehler
Journal:  Int J Toxicol       Date:  2009 Jul-Aug       Impact factor: 2.032

8.  New alkyl N,N-dialkyl-substituted amino acetates as transdermal penetration enhancers.

Authors:  O Wong; J Huntington; T Nishihata; J H Rytting
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

9.  Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative.

Authors:  Adam W G Alani; Joseph R Robinson
Journal:  Pharm Res       Date:  2007-09-11       Impact factor: 4.200

10.  Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: the effect of water and timing of meal intake on oral delivery of Salmon Calcitonin.

Authors:  Morten A Karsdal; Inger Byrjalsen; Bente J Riis; Claus Christiansen
Journal:  BMC Clin Pharmacol       Date:  2008-09-09
View more
  49 in total

Review 1.  Bile acid transporter-mediated oral drug delivery.

Authors:  Feiyang Deng; You Han Bae
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

Review 2.  Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges.

Authors:  Hong Wen; Huijeong Jung; Xuhong Li
Journal:  AAPS J       Date:  2015-08-15       Impact factor: 4.009

Review 3.  Emerging targets and novel approaches to Ebola virus prophylaxis and treatment.

Authors:  Jin Huk Choi; Maria A Croyle
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

Review 4.  Safety concerns over the use of intestinal permeation enhancers: A mini-review.

Authors:  Fiona McCartney; John P Gleeson; David J Brayden
Journal:  Tissue Barriers       Date:  2016-04-12

5.  Laurate permeabilizes the paracellular pathway for small molecules in the intestinal epithelial cell model HT-29/B6 via opening the tight junctions by reversible relocation of claudin-5. [Corrected].

Authors:  Isabel Dittmann; Maren Amasheh; Susanne M Krug; Alexander G Markov; Michael Fromm; Salah Amasheh
Journal:  Pharm Res       Date:  2014-03-15       Impact factor: 4.200

Review 6.  Enhancing the buccal mucosal delivery of peptide and protein therapeutics.

Authors:  Thiago Caon; Liang Jin; Cláudia M O Simões; Raymond S Norton; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-08-29       Impact factor: 4.200

7.  Intestinal surfactant permeation enhancers and their interaction with enterocyte cell membranes in a mucosal explant system.

Authors:  E Michael Danielsen; Gert H Hansen
Journal:  Tissue Barriers       Date:  2017-07-03

Review 8.  Approaches for enhancing oral bioavailability of peptides and proteins.

Authors:  Jwala Renukuntla; Aswani Dutt Vadlapudi; Ashaben Patel; Sai H S Boddu; Ashim K Mitra
Journal:  Int J Pharm       Date:  2013-02-18       Impact factor: 5.875

Review 9.  Controlled release of biologics for the treatment of type 2 diabetes.

Authors:  Caslin A Gilroy; Kelli M Luginbuhl; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2015-12-02       Impact factor: 9.776

10.  Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.

Authors:  David J Brayden; Edwin Walsh
Journal:  AAPS J       Date:  2014-06-25       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.